salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']
Benign neoplasm: other/unspecified salivary gland
CD2_BENIGN_SALIVARY_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
993 |
4. Check minimum number of eventsNone |
993 |
5. Include endpointsNone |
993 |
6. Filter based on genotype QC (FinnGen only) |
993 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: other/unspecified salivary gland
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: other/unspecified salivary gland
- Benign neoplasm of major salivary glands
- Benign neoplasm of major salivary glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7909 | 4345 | 3466 |
| Only index persons | 6218 | 3614 | 2604 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.12 | 0.10 |
| Only index persons | 0.12 | 0.13 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 53.29 | 53.09 | 53.34 |
| Only index persons | 49.87 | 49.80 | 49.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 993 | 541 | 452 |
| Unadjusted period prevalence (%) | 0.19 | 0.18 | 0.20 |
| Median age at first event (years) | 51.51 | 48.48 | 55.14 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 899
- Matched controls
- 8992
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D11.70
ICD-10 Finland
Gland sublingual
+∞
323.0
345
*
ELB30
NOMESCO Finland
Excision of submandibular gland
389.8
240.5
232
8
2102A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Major salivary glands
+∞
235.0
215
*
21020
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Salivary gland
+∞
222.3
204
*
4405
FHL
Partial removal of the parotid gland
1673.7
149.3
141
*
D11.9
ICD-10 Finland
Benign neoplasm: Major salivary gland, unspecified
+∞
135.9
127
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
27.2
101.0
141
61
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
10.1
60.2
125
141
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.6
50.1
137
237
ELB40
NOMESCO Finland
Partial parotidectomy
17.3
43.3
69
43
D11.7
ICD-10 Finland
Benign neoplasm: Other major salivary glands
+∞
43.1
41
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
225.4
42.3
43
*
4404
FHL
Complete removal of the parotid gland
181.8
34.0
35
*
K11.2
ICD-10 Finland
Sialoadenitis
6.8
25.2
65
102
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
44.5
21.5
26
6
4403
FHL
Submandibular gland removal
45.0
18.3
22
5
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
22.3
18.2
26
12
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
17.4
17.5
27
16
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
173.0
16.5
17
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.6
15.8
34
41
D11.71
ICD-10 Finland
Gland submandibular
+∞
15.7
15
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.7
15.5
31
33
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
81.4
14.6
16
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
14.7
14.1
23
16
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
12.6
12.2
21
17
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
11.2
12.1
22
20
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
11.8
249
1584
ELB50
NOMESCO Finland
Total parotidectomy
30.5
11.7
15
5
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.4
11.6
41
96
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
18.1
10.7
16
9
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
10.4
10
*
4704
FHL
Neck tumor removal
32.9
10.3
13
*
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
11.4
10.1
18
16
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
12.3
9.9
17
14
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.4
8.5
24
45
4402
FHL
Removal or exploration of a salivary change (eg ranula)
90.8
8.4
9
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
8.3
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8.6
8.3
17
20
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.1
7.6
16
20
4701
FHL
Neck lymph node removal
25.2
7.6
10
*
ZXA00
NOMESCO Finland
Right side
1.6
7.5
246
1741
WX402
NOMESCO Finland
General anaesthesia
1.8
7.4
131
778
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
7.3
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
8.9
7.1
14
16
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
16.8
6.8
10
6
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
12.3
6.6
11
9
ELB99
NOMESCO Finland
Other excision of salivary gland
70.3
6.4
7
*
4409
FHL
Other measure in this category
70.3
6.4
7
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
14.4
6.4
10
7
K11.70
ICD-10 Finland
Hypoptyalism
8.2
6.3
13
16
TQA05
NOMESCO Finland
Puncture of skin of head or neck
+∞
6.3
6
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
6.3
6
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
6.3
6
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.6
6.2
41
160
ZXA05
NOMESCO Finland
Left side
1.5
6.1
231
1679
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
129
211
6.88
77.34
1.3
1.2
—
—
—
0
0
541
4567
1.41
6.42
9.3
8.9
4.2
4.2
e9/l
0.27
479
3990
144
943
1.62
6.17
3.8
3.9
250.4
248.8
u/l
0.03
133
887
18
49
3.72
5.94
1.3
1.2
—
—
—
0
0
12
26
4.66
5.27
1.1
1.0
—
—
—
0
0
428
3659
1.30
3.93
5.2
4.7
35.0
35.1
g/l
0.07
405
3392
309
2541
1.31
3.74
2.6
2.4
56.9
56.4
u/l
0.06
286
2341
479
4185
1.28
3.61
8.1
6.7
1.2
1.2
mmol/l
0.16
409
3526
10
27
3.73
3.36
2.2
3.2
—
—
—
0
0
10
27
3.73
3.36
2.2
3.2
—
—
—
0
0
180
1399
1.35
3.18
2.7
2.8
1.1
1.1
e6/l
0.04
116
818
350
2987
1.27
3.07
3.4
3.3
—
—
—
0
0
276
2292
1.28
3.01
3.1
3.2
0.3
0.5
e6/l
2.86
212
1767
146
1107
1.37
3.01
6.4
5.2
1.0
1.0
mmol/l
0.33
138
1012
485
4309
1.25
2.96
6.3
6.0
10.8
11.5
umol/l
1.28
461
4081
61
395
1.58
2.82
6.4
3.7
48.8
48.3
%
0.05
61
390
169
1328
1.33
2.77
3.3
3.1
0.8
0.8
mmol/l
0.20
159
1230
107
782
1.41
2.75
4.4
3.4
2.2
2.0
mmol/l
0.21
89
618
105
768
1.41
2.69
2.4
2.6
5.6
7.0
ug/l
0.57
93
672
295
2522
1.24
2.46
2.4
2.2
205.1
239.0
u/l
0.32
272
2374
51
329
1.58
2.43
1.8
2.1
36.5
39.4
u/l
0.50
44
289
20
97
2.08
2.38
1.3
1.4
—
—
—
0
0
136
1063
1.32
2.32
5.7
6.8
104.5
104.2
mmol/l
0.41
127
1039
430
3840
1.21
2.32
6.8
5.9
1.2
1.2
mmol/l
0.13
390
3462
667
6223
1.22
2.25
8.3
7.5
81.3
79.8
u/l
0.27
624
5820
585
5394
1.21
2.21
4.9
4.7
1281.6
2808.4
e6/l
—
9
91
163
1316
1.29
2.20
2.8
3.0
2.4
2.3
e6/l
0.04
100
740
526
4810
1.20
2.15
5.3
4.7
7.0
6.8
mmol/l
2.11
499
4510
87
644
1.38
2.12
2.8
2.9
68.3
61.6
ml/min/173m2
0.70
38
275
28
161
1.76
2.07
1.5
1.3
—
—
—
0
0
43
279
1.57
2.03
3.5
4.3
3.9
3.9
mmol/l
0.23
34
259
33
202
1.66
1.97
4.8
2.6
7.8
8.0
kpa
0.19
33
183
418
3772
1.19
1.91
4.6
4.1
—
—
—
0
0
192
1614
1.24
1.84
4.6
3.9
261.5
349.9
ng/l
0.36
159
1322
29
175
1.68
1.84
2.9
2.4
16.1
16.1
%
0.02
17
88
210
1784
1.22
1.82
2.7
2.6
6.1
5.4
e6/l
0.32
177
1589
53
370
1.46
1.81
2.5
1.9
4.4
2.1
ug/l
0.35
48
331
9
35
2.59
1.80
3.3
1.9
—
—
—
0
0
159
1314
1.25
1.78
3.1
2.5
11.5
12.7
umol/l
1.25
145
1219
87
665
1.34
1.77
4.7
3.7
98.5
87.9
ng/l
0.48
73
581
147
1206
1.26
1.75
3.0
2.5
2.3
2.3
g/l
0.51
134
1118
145
1188
1.26
1.75
28.7
26.8
1.4
1.3
inr
0.50
31
151
80
1043
0.75
1.75
5.0
4.7
32.8
32.6
%
0.03
47
699
12
54
2.24
1.74
1.0
1.3
—
—
—
0
0
14
68
2.07
1.70
1.1
1.1
—
—
—
0
0
14
68
2.07
1.70
2.2
1.9
2.2
2.3
u/field
—
5
24
125
1011
1.27
1.69
7.0
7.1
5.0
5.1
kpa
1.04
117
968
125
1012
1.27
1.67
7.0
7.1
11.7
12.0
kpa
0.26
118
970
49
343
1.45
1.67
1.6
2.5
4.0
3.8
g/l
0.28
35
249
18
97
1.87
1.67
1.1
1.5
69.3
64.6
%
—
8
65
93
725
1.31
1.66
9.6
6.9
10.4
10.4
mmol/l
0.02
86
690
324
2890
1.18
1.65
3.5
3.5
2.3
2.4
mmol/l
0.76
285
2498
365
3288
1.17
1.65
2.2
2.3
77.7
78.5
nmol/l
0.21
327
2912
75
567
1.35
1.65
9.7
7.1
24.8
24.7
mmol/l
0.07
67
536
49
344
1.45
1.65
1.6
2.5
7.4
7.6
g/l
0.20
35
259
49
344
1.45
1.65
1.6
2.5
—
—
—
0
0
125
1014
1.27
1.65
1.4
1.4
—
—
—
0
0
125
1014
1.27
1.65
7.0
7.1
1.9
1.3
mmol/l
0.75
95
802
34
222
1.55
1.61
1.8
1.6
—
—
—
0
0
94
741
1.30
1.56
2.0
3.0
65.7
66.5
g/l
0.50
89
673
227
1976
1.19
1.53
2.2
2.3
—
—
—
0
0
41
284
1.46
1.50
2.9
3.9
91.9
77.6
mg/l
0.13
35
230
41
284
1.46
1.50
2.9
3.9
36.7
45.6
mg/l
0.34
35
232
23
139
1.67
1.49
1.2
1.3
—
—
—
0
0
296
2643
1.17
1.47
4.0
3.9
10.5
9.4
mg/mmol
0.16
181
1669
288
2566
1.17
1.47
3.1
3.1
7.0
7.2
mmol/l
0.33
235
2132
664
6297
1.16
1.47
22.8
19.0
13.9
13.8
%
0.98
651
6161
40
277
1.46
1.47
2.9
3.9
1.4
1.9
ratio
—
6
25
714
6811
1.17
1.46
19.6
16.8
38.8
39.1
%
0.31
490
4537
360
3274
1.16
1.40
3.3
2.7
128.3
138.7
ug/l
0.42
330
2992
45
322
1.42
1.40
1.5
2.6
8.7
10.3
g/l
2.33
39
275
68
523
1.32
1.37
4.2
3.6
2.7
1.9
mmol/l
1.09
49
408
182
1571
1.19
1.35
1.2
1.2
1.0
1.5
u/ml
0.85
41
405
113
931
1.24
1.33
3.2
4.1
11.7
28.4
ug/l
0.91
94
774
425
3925
1.14
1.32
4.3
3.9
0.0
0.0
estimate
0.80
69
702
0
41
0.00
1.31
0.0
1.1
—
—
—
0
0
30
202
1.50
1.28
2.4
1.7
—
—
—
0
0
10
48
2.09
1.28
1.1
1.2
—
—
—
0
0
44
320
1.39
1.27
1.6
2.6
3.1
3.2
g/l
0.09
35
253
19
115
1.66
1.25
1.6
1.9
33.2
32.4
pg
0.45
19
115
6
25
2.41
1.24
1.0
1.7
18.7
16.0
pmol/l
—
6
18
91
742
1.25
1.19
2.1
2.3
33.2
35.9
u/l
0.29
77
627
8
38
2.11
1.18
1.1
1.3
—
—
—
0
0
382
3523
1.14
1.18
2.2
2.1
93.9
94.3
pmol/l
0.06
210
1800
20
125
1.61
1.18
1.3
1.2
9.5
10.9
u/l
0.21
13
98
418
3878
1.13
1.18
5.8
5.2
0.0
0.0
estimate
0.00
70
722
277
2501
1.15
1.17
3.4
3.1
33.1
32.0
u/l
0.14
261
2375
0
34
0.00
1.16
0.0
1.7
—
53.3
—
0
34
133
1134
1.20
1.14
3.3
2.5
19.9
22.4
%
1.37
117
966
27
183
1.49
1.14
2.2
2.1
131.5
128.7
g/l
0.18
22
132
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
293
1.38
1.13
2.9
2.4
0.4
0.4
u/ml
0.16
22
166
99
824
1.22
1.09
7.1
7.9
119.3
120.3
g/l
0.20
93
799
106
889
1.22
1.09
3.5
3.4
—
—
—
0
0
7
33
2.13
1.05
3.1
2.8
1482.1
1271.0
u/ml
—
7
33
7
33
2.13
1.05
2.9
4.2
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
232.6
194.6
iu/ml
—
5
22
414
3864
1.12
1.03
4.3
3.9
0.0
0.0
estimate
0.00
69
720
7
34
2.07
1.03
2.1
1.3
—
—
—
0
0
24
163
1.48
1.02
1.1
1.1
—
—
—
0
0
620
5930
1.12
0.99
4.5
4.0
15.1
14.9
pmol/l
0.67
552
5336
89
742
1.22
0.98
2.8
3.1
289.8
230.7
ng/l
0.39
76
681
236
2135
1.14
0.97
2.7
2.7
13124.7
7204.6
umol/l
0.51
206
1815
148
1296
1.17
0.96
1.3
1.3
28.6
33.1
iu/ml
0.32
58
405
90
754
1.21
0.95
1.6
1.7
1.5
1.5
%
0.04
80
633
11
62
1.78
0.94
1.5
1.1
—
103.6
—
0
7
16
101
1.59
0.94
1.4
1.2
0.7
0.6
nmol/l
0.26
16
92
29
210
1.39
0.91
2.7
2.5
88.4
84.7
ug/min
0.03
19
124
187
1674
1.14
0.90
3.4
3.1
2.5
2.5
mmol/l
0.15
167
1478
5
102
0.49
0.89
1.0
1.0
—
—
—
0
0
611
5867
1.11
0.84
4.6
4.2
14.5
13.5
mm/h
0.78
565
5386
321
2984
1.11
0.83
4.8
4.2
—
—
—
0
0
192
1733
1.13
0.83
5.1
4.3
1.0
1.0
kg/l
0.21
22
249
794
7738
1.13
0.82
19.3
15.6
26.3
25.2
mg/l
0.41
660
6245
11
65
1.70
0.82
1.1
1.2
2.2
1.6
nmol/l
0.89
11
57
8
47
1.71
0.80
1.0
1.6
—
—
—
0
0
8
47
1.71
0.80
1.0
1.6
—
—
—
0
0
350
3275
1.11
0.80
4.7
3.9
41.7
48.7
ng/l
0.24
255
2409
43
540
0.79
0.80
2.1
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
16
106
1.52
0.79
1.4
1.6
—
—
—
0
0
8
48
1.67
0.79
2.8
2.4
—
—
—
0
0
9
53
1.70
0.75
1.4
1.5
—
—
—
0
0
36
280
1.30
0.75
3.2
2.8
—
—
—
0
0
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
14
92
1.53
0.72
5.5
2.8
—
—
—
0
0
29
221
1.32
0.70
1.3
1.5
0.3
0.2
g/l
0.41
29
211
15
101
1.49
0.70
1.2
1.1
—
21.3
—
0
5
41
328
1.26
0.70
1.0
1.0
—
—
—
0
0
16
110
1.46
0.68
2.1
1.8
87.9
89.9
%
0.51
16
110
12
78
1.55
0.65
1.0
1.4
—
—
—
0
0
15
103
1.46
0.65
1.2
1.1
—
—
—
0
0
30
233
1.30
0.65
1.3
1.5
1.2
1.2
g/l
0.26
30
223
15
104
1.45
0.62
1.4
1.6
—
—
—
0
0
15
104
1.45
0.62
1.3
1.6
—
—
—
0
0
15
104
1.45
0.62
1.4
1.6
—
—
—
0
0
25
191
1.32
0.61
1.2
1.4
—
—
—
0
0
15
105
1.44
0.60
1.3
1.6
—
—
—
0
0
730
7127
1.09
0.59
5.4
4.8
2.0
2.1
mu/l
0.50
667
6435
19
140
1.36
0.58
1.1
1.7
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
115
1031
1.13
0.58
1.4
1.4
—
—
—
0
0
15
106
1.42
0.58
1.4
1.6
—
—
—
0
0
16
115
1.40
0.57
1.3
2.7
—
752.9
—
0
11
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
748
7320
1.09
0.54
17.6
14.5
76.3
76.4
ml/min/173m2
0.07
638
6074
9
60
1.50
0.54
1.3
1.5
—
—
—
0
0
169
1831
0.91
0.54
1.7
1.7
462.1
15451943.6
pmol/l
1.33
144
1495
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
231
2162
1.09
0.53
4.6
4.5
22.5
21.5
%
0.48
110
1109
27
214
1.27
0.53
2.0
3.1
0.7
0.8
nmol/l
0.66
18
170
71
621
1.15
0.52
1.7
1.7
—
—
—
0
0
9
63
1.43
0.52
1.0
1.0
—
—
—
0
0
115
1040
1.12
0.52
8.5
7.9
—
—
—
0
0
28
225
1.25
0.50
1.7
1.5
—
—
—
0
0
7
111
0.63
0.48
1.3
2.7
—
24.8
—
0
26
28
227
1.24
0.47
1.4
1.3
—
—
—
0
0
7
48
1.46
0.47
1.7
1.3
—
—
—
0
0
7
48
1.46
0.47
1.7
1.3
—
—
—
0
0
61
534
1.15
0.46
5.9
9.0
94.1
93.9
%
0.13
61
529
32
265
1.21
0.45
1.2
1.3
—
—
—
0
0
19
148
1.29
0.43
5.9
3.6
56.6
58.6
%
0.35
19
148
24
193
1.25
0.43
1.1
1.6
—
—
—
0
0
5
32
1.57
0.42
1.0
1.8
—
—
—
0
0
5
32
1.57
0.42
1.0
1.8
—
—
—
0
0
57
501
1.15
0.42
1.5
1.5
—
—
—
0
0
226
2136
1.08
0.42
5.0
4.2
0.0
0.0
estimate
0.50
63
692
8
58
1.38
0.41
1.0
1.5
—
—
—
0
0
5
33
1.52
0.41
1.0
1.8
—
—
—
0
0
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
24
195
1.24
0.40
1.3
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
29
241
1.21
0.40
1.2
1.2
—
—
—
0
0
18
141
1.28
0.40
5.1
3.3
4.1
4.4
e9/l
0.22
18
141
29
242
1.20
0.39
1.2
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
15
115
1.31
0.39
1.1
1.6
—
—
—
0
0
12
89
1.35
0.38
1.0
1.7
—
—
—
0
0
9
68
1.33
0.37
1.0
1.6
—
—
—
0
0
30
253
1.19
0.37
1.3
1.4
263.5
290.5
ug/g
0.39
21
156
824
8136
1.08
0.36
22.0
18.4
4.0
4.0
mmol/l
0.92
805
7894
822
8116
1.07
0.36
21.6
18.2
139.7
139.7
mmol/l
0.18
804
7886
6
43
1.40
0.35
1.2
1.6
—
—
—
0
0
6
43
1.40
0.35
1.2
1.6
—
—
—
0
0
6
43
1.40
0.35
1.2
1.6
—
—
—
0
0
6
43
1.40
0.35
1.2
1.6
—
—
—
0
0
20
163
1.23
0.34
1.3
1.2
—
—
—
0
0
202
2125
0.94
0.34
1.5
1.6
1.4
1.4
mmol/l
0.19
164
1757
6
45
1.34
0.33
1.2
1.1
154.8
495.5
u/l
—
6
40
22
182
1.21
0.33
1.3
1.7
—
—
—
0
0
28
238
1.18
0.32
1.3
2.1
—
—
—
0
0
24
201
1.20
0.32
1.1
1.6
—
—
—
0
0
50
447
1.12
0.31
1.3
1.2
80.0
121.1
iu/ml
0.85
15
175
7
53
1.32
0.31
2.0
1.6
—
—
—
0
0
21
175
1.20
0.30
1.3
1.5
—
—
—
0
0
224
2143
1.06
0.30
2.8
2.1
3.3
3.1
mg/l
0.48
199
1813
427
4155
1.05
0.30
2.6
2.6
—
—
—
0
0
23
195
1.18
0.28
1.1
1.2
440.8
499.3
mg/l
0.79
23
185
11
85
1.30
0.28
1.1
1.1
—
—
—
0
0
11
85
1.30
0.28
1.2
1.7
—
—
—
0
0
217
2081
1.05
0.27
1.6
1.6
20.9
20.5
nmol/l
0.13
187
1753
17
141
1.21
0.26
1.3
1.7
—
—
—
0
0
5
72
0.69
0.26
1.8
1.5
—
—
—
0
0
163
1554
1.06
0.25
2.9
3.1
0.8
0.8
ug/l
0.08
109
1071
45
406
1.11
0.25
1.8
1.8
—
—
—
0
0
9
76
1.19
0.24
1.3
1.5
—
—
—
0
0
9
76
1.19
0.24
1.3
1.5
—
—
—
0
0
9
76
1.19
0.24
1.3
1.5
—
—
—
0
0
12
96
1.25
0.24
3.6
3.6
—
—
—
0
0
181
1736
1.05
0.23
1.6
1.6
1.4
1.3
mg/l
0.21
136
1350
770
7619
1.05
0.23
5.3
4.9
6.2
6.0
mmol/l
1.91
692
6889
7
91
0.77
0.22
1.1
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
40
362
1.11
0.22
1.6
1.7
—
—
—
0
0
10
79
1.27
0.22
1.3
1.0
0.1
1.0
u/ml
—
5
30
75
701
1.08
0.22
2.3
2.1
355.5
376.6
nmol/l
0.34
65
637
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
11.6
—
6.2
—
0
12
87
923
0.94
0.21
2.8
2.6
4.7
8.3
umol/l
6.35
75
802
741
7333
1.04
0.21
7.2
6.1
40.7
40.3
mmol/mol
0.59
678
6739
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
19
219
0.86
0.20
1.1
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
28.7
—
0
9
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
16
136
1.18
0.20
1.2
1.5
—
—
—
0
0
9
115
0.78
0.20
2.0
1.5
—
—
—
0
0
55
510
1.08
0.20
2.1
1.8
—
—
—
0
0
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
14
118
1.19
0.19
1.2
1.5
—
—
—
0
0
14
118
1.19
0.19
1.2
1.5
—
—
—
0
0
827
8208
1.05
0.19
12.3
10.8
25.2
25.1
u/l
0.06
796
7886
7
58
1.21
0.18
1.9
2.1
—
159.8
—
0
10
27
243
1.11
0.17
2.1
1.8
2.6
2.8
mg/l
0.08
20
191
5
66
0.76
0.17
1.6
1.5
—
—
—
0
0
5
66
0.76
0.17
1.6
1.5
—
—
—
0
0
5
66
0.76
0.17
1.6
1.5
—
—
—
0
0
5
67
0.75
0.17
1.2
1.1
—
—
—
0
0
15
173
0.87
0.16
1.2
1.3
—
—
—
0
0
9
78
1.16
0.15
1.2
1.8
—
—
—
0
0
9
79
1.14
0.15
6.6
2.5
—
—
—
0
0
728
7338
0.97
0.14
4.4
4.1
1.3
1.3
mmol/l
1.29
646
6643
19
169
1.13
0.14
2.0
1.7
—
—
—
0
0
275
2692
1.03
0.14
4.9
5.2
2.7
3.4
ug/l
0.58
241
2382
14
123
1.14
0.12
1.0
1.1
—
—
—
0
0
492
4863
1.02
0.12
3.3
3.1
59.9
51.6
u/l
0.72
455
4481
11
126
0.87
0.11
2.0
1.5
—
—
—
0
0
176
1720
1.03
0.11
1.8
1.8
1167.9
1181.8
nmol/l
0.06
136
1291
10
86
1.16
0.11
1.1
1.0
2.2
1.5
u/ml
—
5
29
37
349
1.06
0.10
2.1
1.9
—
—
—
0
0
5
44
1.14
0.10
2.4
2.5
—
—
—
0
0
5
47
1.06
0.09
2.2
1.4
—
—
—
0
0
52
498
1.05
0.09
2.3
2.2
10.0
12.5
nmol/l
1.71
47
435
6
54
1.11
0.09
1.3
1.2
130.8
73.1
u/l
—
6
48
30
318
0.94
0.08
2.2
1.7
—
—
—
0
0
7
64
1.09
0.08
1.4
1.2
13.6
14.6
u/l
—
7
56
7
65
1.08
0.08
2.3
1.7
—
—
—
0
0
6
73
0.82
0.07
2.3
1.7
—
—
—
0
0
20
186
1.08
0.07
1.2
1.7
1.3
5.0
iu/l
—
6
53
268
2649
1.02
0.06
3.9
3.0
1816.4
1569.1
ng/l
0.34
225
2282
126
1239
1.02
0.05
1.3
1.3
5.0
11.7
u/ml
1.33
48
460
761
7585
1.01
0.05
4.8
4.6
1.4
1.5
mmol/l
1.75
686
6906
852
8499
1.02
0.05
28.2
23.0
132.7
133.7
g/l
1.11
841
8340
16
169
0.95
0.03
1.6
1.3
—
—
—
0
0
16
169
0.95
0.03
1.6
1.3
—
—
—
0
0
143
1444
0.99
0.03
2.0
1.8
—
—
—
0
0
16
152
1.05
0.02
1.2
1.5
—
—
—
0
0
763
7640
0.99
0.01
4.9
4.7
4.6
4.6
mmol/l
0.51
691
7011
102
1014
1.01
0.00
1.9
1.8
—
—
—
0
0
781
7816
1.00
0.00
5.6
5.2
2.7
2.7
mmol/l
0.43
711
7124
18
182
0.99
0.00
3.4
3.6
19.9
28.1
mg/l
0.44
12
114
102
1021
1.00
0.00
1.9
1.8
—
—
—
0
0
35
353
0.99
0.00
1.3
1.3
—
—
—
0
0
22
225
0.98
0.00
1.8
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
12
120
1.00
0.00
1.1
1.1
—
—
—
0
0
5
53
0.94
0.00
1.2
1.4
—
53.3
—
0
6
6
62
0.97
0.00
1.3
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
12.2
—
0
9
8
89
0.90
0.00
1.0
1.1
1.6
1.5
g/l
—
8
81
5
54
0.93
0.00
2.4
1.3
11.2
14.5
u/l
—
5
48
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
14.0
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_SALIVARY_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SALIVARY_NOS | 1.304 [1.12, 1.52] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.225 |
During the follow-up period (1.1.1998 — 31.12.2019), 403 out of 1694 females with CD2_BENIGN_SALIVARY_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_SALIVARY_NOS | 1.63 [1.38, 1.93] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 407 out of 1374 males with CD2_BENIGN_SALIVARY_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_SALIVARY_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.084% | 0.371% |
| 5 | 0.664% | 1.865% |
| 10 | 1.9% | 4.564% |
| 15 | 3.672% | 8.531% |
| 20 | 6.75% | 14.404% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SALIVARY_NOS – Benign neoplasm: other/unspecified salivary gland
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data